1. Market Research
  2. > Healthcare Market Trends
  3. > mHealth Market (Devices, Applications, Services and Therapeutics) - Global Mobile Healthcare Industry Size, Analysis, Share, Growth, Trends and Forecast, 2012 - 2020

Currently, mobile penetration is more than 100% in developed markets and is rapidly increasing in developing markets such as Asia-Pacific, Latin America and Africa. Moreover, increasing exposure to smartphones along with 3G and 4G networks will further boost the adoption of mobile devices in most sectors, especially in healthcare systems. Furthermore, shift is observed from hospital-care to personal-care, as Mobile Healthcare systems are providing seamless support and care to patients irrespective of their locations. On top of that, the advent of new generation of connected medical devices is making it easier for healthcare providers to serve patients effectively and at a lower cost. Mobile medical devices provides adequate and systematic recording of biomedical signals such as respiratory parameters, glucose analysis, electrocardiogram (ECG) recordings and blood pressure measurements irrespective of the location. Thus, major factors that mobile health market players use to differentiate their product and services are portability, automation, ease of use and customization. These have proved to be an optimal solution for monitoring and diagnosing of chronic conditions. Thus, mobile access is expected to become ubiquitous part of healthcare system over next few years, worldwide, just like healthcare access.Increasing number of active subscribers and growing coverage of mobile networks is primarily driving the demand for smart and connected devices, which in turn is steering the growth of Mobile Healthcare Market. On top of that, increase in incidence of lifestyle driven diseases, namely diabetes and obesity, which is enabling the mobile healthcare devices market growth. In spite of technological advancement in medical devices and rise in per capita income, the higher cost of healthcare systems poses challenges such as affordability and complexity worldwide. In developed markets, due to rise in chronic diseases, per capita expenditure on healthcare is increasing at a faster rate than increase in income level and inflation rate. Yet, there has been no corresponding increase in quality of healthcare services rendered in many countries, thus can be treated as an opportunity for Mobile Health Market. On the other hand, developing countries are still struggling to provide adequate healthcare solutions to their citizens.Owing to factors detailed above, the global mobile health (mHealth) market is estimated to reach $58.8 billion by the end of 2020 at a CAGR of 32.3% between 2013 and 2020. Blood Glucose Meters market is projected to lead the mHealth devices market followed by cardiac monitoring devices during the forecast period (2013 ‐ 2020). Increasing emphasis on preventive medication is expected to drive the mHealth service market. Monitoring services is expected to take away major chunk of the market with most of the revenue coming from the developed regions.Europe leads the regional market landscape of the global mHealth market followed by Asia Pacific and North America. Furthermore, by 2020, Asia Pacific will take away the lead from North America, occupying more than 28.2% of the market. The players profiled in this report include: Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofie, Boston Scientific, AT&T Inc., and Johnson & Johnson.

KEY BENEFITS
This report identifies and analyzes factors that accelerate the market growth driven by increase in lifestyle diseases, integration of wireless technologies with portable healthcare devices, technological innovations, cost and convenience factors and government initiativesReport analyzes 2012 market and forecasts demand for mHealth market through 2020. The report is segmented by mobile compatible monitoring devices, mHealth services, stakeholders, therapeutic area and geographic regionsCompetitive analysis to effectively plan and execute business planIdentification of key application segments based on future potential and growth prospectsIdentification of key players and their business performance analysis based on strategies followed by themTop factors that are expected to affect the growth of the market along with impact analysis of every such factorExamine the challenges that must be addressed and overcome in the mHealth market to achieve fiscal success throughout the mHealth marketReport provides regulatory framework regulates introduction of new mobile compatible medical devicesAnalysis of the market factors in various geographic regions and help understand business opportunities

KEY MARKET SEGMENTS
GLOBAL MARKET, BY EQUIPMENTBlood Glucose MetersBP MonitorsPulse OximetersNeurological MonitoringCardiac MonitorsApnea & Sleep MonitorWearable fitness sensor device and Heart Rate MetersOthersGLOBAL MARKET, BY SERVICEWellness Services MarketPrevention Services MarketTreatment Services MarketDiagnosis Service MarketMonitoring Services MarketHealthcare Systems Strengthening Solutions MarketGLOBAL MARKET, BY STAKEHOLDERSMobile OperatorsDevice VendorsHealthcare ProvidersApplication PlayersGLOBAL MARKET, BY THERAPEUTIC SEGMENTCardiovascularDiabetesRespiratoryNeurologyOthersGLOBAL MARKET,

BY GEOGRAPHY
North AmericaEuropeAsia PacificRest of the World

KEY AUDIENCES
Medical Devices ManufacturersTelecommunications Services ProvidersResearch InstitutionsHealthcare InstitutionsContent/Application Players

Table Of Contents

mHealth Market (Devices, Applications, Services and Therapeutics) - Global Mobile Healthcare Industry Size, Analysis, Share, Growth, Trends and Forecast, 2012 - 2020
CHAPTER 1 INTRODUCTIONandnbsp;1.1. Scope and Coverageandnbsp;1.2. Report Descriptionandnbsp;1.3. Research MethodologyCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 GLOBALandnbsp; MOBILE HEALTHCARE (mHEALTH) MARKET OVERVIEWandnbsp;3.1. Market Definition and Scopeandnbsp;3.2. Key Findingsandnbsp;andnbsp;andnbsp; 3.2.1. Top Ten Factors Impacting mHealth Marketandnbsp;andnbsp;andnbsp; 3.2.2. Top Three Winning Strategies In the mHealth Marketandnbsp;andnbsp;andnbsp; 3.2.3. Global m-Health Market Players Positioningandnbsp;andnbsp;andnbsp; 3.2.4. Top Investment Pockets in mHealth marketandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.4.1. mHealth Device Marketandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.4.2. mHealth Service Marketandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.4.3. mHealth Stakeholders Marketandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.2.4.4. mHealth market by Therapeuticandnbsp;3.3. Porterandrsquo;s Five Force analysisandnbsp;andnbsp;andnbsp; 3.3.1. Bargaining power of supplier clearly differ within m-Health devices and services marketandnbsp;andnbsp;andnbsp; 3.3.2. Technology enhancement key to increased bargaining power among the buyersandnbsp;andnbsp;andnbsp; 3.3.3. Competition among market players to get tougher over timeandnbsp;andnbsp;andnbsp; 3.3.4. Possible New Entrants from Conventional Product Manufacturersandnbsp;andnbsp;andnbsp; 3.3.5. Conventional Testing Methods Pose Challenge to mHealth Market Playersandnbsp;3.4. Regulatory Issues, Legislations and Authoritiesandnbsp;andnbsp;andnbsp; 3.4.1. Regulations and Directives pertaining to mHealth in the U.S.andnbsp;andnbsp;andnbsp; 3.4.2. Regulations and Directives pertaining to mHealth in EUandnbsp;3.5. Insurance Reimbursement Scenarioandnbsp;3.6. Market Dynamicsandnbsp;andnbsp;andnbsp; 3.6.1. Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.1. Integration of wireless technologies with portable healthcare devicesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.2. Increasing Lifestyle Diseaseandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.3. Cost and Convenience Factorsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.4. Technological Innovationsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.5. Government Initiativesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.1.6. Affordability of Smartphonesandnbsp;andnbsp;andnbsp; 3.6.2. Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.2.1. Lower Adoption due to Lack of Accuracy and Technology Infancyandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.2.2. Weak Reimbursement Coverageandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.2.3. Technological Awareness Among the Ageing Populationandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.2.4. Uncertainty in the Government Regulations is Responsible for Mundane Growth Rateandnbsp;andnbsp;andnbsp; 3.6.3. Opportunitiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.3.1. Untapped Market of Developing Economiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.6.3.2. Rising Opportunities for Mobile Medical Devices Manufacturers in the form of Bundled Servicesandnbsp;3.7. Advancing Wireless Technologiesandnbsp;andnbsp;andnbsp; 3.7.1. 3Gandnbsp;andnbsp;andnbsp; 3.7.2. 4Gandnbsp;andnbsp;andnbsp; 3.7.3. Zigbeeandnbsp;andnbsp;andnbsp; 3.7.4. Wimaxandnbsp;andnbsp;andnbsp; 3.7.5. Othersandnbsp;3.8. Case Study: Monitoring and Supporting Patients With Hypertension Over Blackberry SmartphonesCHAPTER 4 GLOBALandnbsp; MOBILE HEALTHCARE (mHEALTH) MARKET - BY DEVICESandnbsp;4.1. Blood Glucose Metersandnbsp;andnbsp;andnbsp; 4.1.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.1.2. Market Trendsandnbsp;andnbsp;andnbsp; 4.1.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.1.3.1. Rise in Incidences of Diabetesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.1.3.2. Round-the-Clock Monitoringandnbsp;andnbsp;andnbsp; 4.1.4. Market Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.1.4.1. Accuracy an Issueandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.1.4.2. Complexityandnbsp;andnbsp;andnbsp; 4.1.5. Market Opportunitiesandnbsp;4.2. BP Monitorsandnbsp;andnbsp;andnbsp; 4.2.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.2.2. Market Trendsandnbsp;andnbsp;andnbsp; 4.2.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.2.3.1. Rise in Incidences of Hypertensionandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.2.3.2. Need to Continuously Monitor BPandnbsp;andnbsp;andnbsp; 4.2.4. Market Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.2.4.1. Accuracy as a Concernandnbsp;andnbsp;andnbsp; 4.2.5. Market Opportunitiesandnbsp;4.3. Pulse Oximetersandnbsp;andnbsp;andnbsp; 4.3.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.3.2. Market Trendsandnbsp;andnbsp;andnbsp; 4.3.3. Key Market Driversandnbsp;andnbsp;andnbsp; 4.3.4. Market Restraintsandnbsp;andnbsp;andnbsp; 4.3.5. Market Opportunityandnbsp;4.4. Neurological Monitoringandnbsp;andnbsp;andnbsp; 4.4.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.4.2. Market Trendsandnbsp;andnbsp;andnbsp; 4.4.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.4.3.1. Increase in Incidences of Neurological Disordersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.4.3.2. Technological Advancementandnbsp;andnbsp;andnbsp; 4.4.4. Market Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.4.4.1. High Priceandnbsp;andnbsp;andnbsp; 4.4.5. Market Opportunityandnbsp;4.5. Cardiac Monitorsandnbsp;andnbsp;andnbsp; 4.5.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.5.2. Market Trendsandnbsp;andnbsp;andnbsp; 4.5.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.5.3.1. Rising Incidences of Heart Diseasesandnbsp;andnbsp;andnbsp; 4.5.4. Market Restraintandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.5.4.1. Standardization and Inter-Operability a Concernandnbsp;andnbsp;andnbsp; 4.5.5. Market Opportunityandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.5.5.1. Lack of Trained Healthcare Professionalsandnbsp;4.6. Apnea andamp; Sleep Monitorandnbsp;andnbsp;andnbsp; 4.6.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.6.2. Market Trendandnbsp;andnbsp;andnbsp; 4.6.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.6.3.1. Large Patient Pool in the U.S.andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.6.3.2. Increasing Awarenessandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.6.3.3. Government Regulationsandnbsp;andnbsp;andnbsp; 4.6.4. Market Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.6.4.1. Ignoring the Existing Sleeping Disorderandnbsp;andnbsp;andnbsp; 4.6.5. Market Opportunitiesandnbsp;4.7. Wearable Fitness Sensor Device and Heart Rate Metersandnbsp;andnbsp;andnbsp; 4.7.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 4.7.2. Market Trendandnbsp;andnbsp;andnbsp; 4.7.3. Key Market Driversandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.7.3.1. Increase in Adoption due to Health Consciousnessandnbsp;andnbsp;andnbsp; 4.7.4. Market Restraintsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.7.4.1. Cost as a Constraintandnbsp;andnbsp;andnbsp; 4.7.5. Market Opportunityandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 4.7.5.1. Targeting Effluent Pockets of Developing Economiesandnbsp;4.8. OthersCHAPTER 5 GLOBAL MOBILE HEALTHCARE (mHEALTH) MARKET - BY SERVICEandnbsp;5.1. Market Size and Forecast, by Geography, 2012 anddash; 2020 ($million)andnbsp;5.2. Key Driversandnbsp;andnbsp;andnbsp; 5.2.1.andnbsp; Rising Healthcare Expenditureandnbsp;andnbsp;andnbsp; 5.2.2.andnbsp; Need To Continuous Monitor Elderly Populationandnbsp;andnbsp;andnbsp; 5.2.3. Burden of Managing Non-Communicable Diseases as well as Pre-Existing Burden of Communicable Diseasesandnbsp;5.3. Market Restraintsandnbsp;andnbsp;andnbsp; 5.3.1. Physicians Acceptanceandnbsp;andnbsp;andnbsp; 5.3.2. Reluctance of Individual in Adoption of mHealth Solutionsandnbsp;5.4. Market Opportunitiesandnbsp;andnbsp;andnbsp; 5.4.1. Opportunities in Developing Economiesandnbsp;andnbsp;andnbsp; 5.4.2. Increase in Smartphone Penetration Creates Opportunity for Allied Servicesandnbsp;5.5. mHealth Services Market Segmentationandnbsp;andnbsp;andnbsp; 5.5.1. Wellness Services Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.2. Prevention Services Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.3. Treatment Services Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.4. Diagnosis Service Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.5. Monitoring Services Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.6. Healthcare Systems Strengthening Solutions Market anddash; Global and Geography, 2012 anddash; 2020 ($million)andnbsp;andnbsp;andnbsp; 5.5.7. Other Services And Applications Market anddash; Global and Geography, 2012 anddash; 2020 ($million)CHAPTER 6 GLOBAL MOBILE HEALTHCARE (mHEALTH) MARKET anddash; BY STAKEHOLDERSandnbsp;6.1. Mobile Operators Market, 2012 anddash; 2020 ($million)andnbsp;6.2. Device Vendors Market, 2012 anddash; 2020 ($million)andnbsp;6.3. Healthcare Providers Market, 2012 anddash; 2020 ($million)andnbsp;6.4. Application Players Market, 2012 anddash; 2020 ($million)CHAPTER 7 GLOBAL MOBILE HEALTHCARE (mHEALTH) MARKET - BY THERAPEUTIC SEGMENT/SPECIALTYandnbsp;7.1. Cardiovascular Market, 2012 anddash; 2020 ($million)andnbsp;7.2. Diabetes Market, 2012 anddash; 2020 ($million)andnbsp;7.3. Respiratory Market, 2012 anddash; 2020 ($million)andnbsp;7.4. Neurology Market, 2012 anddash; 2020 ($million)andnbsp;7.5. Others Market, 2012 anddash; 2020 ($million)CHAPTER 8 GLOBALandnbsp; MOBILE HEALTHCARE (mHEALTH) MARKET - BY GEOGRAPHYandnbsp;8.1. Impact Analysis Pertaining to Geographyandnbsp;8.2. North America Mobile Healthcare Market, 2012 anddash; 2020 ($million)andnbsp;8.3. Europe Mobile Healthcare Market, 2012 anddash; 2020 ($million)andnbsp;8.4. Asia Pacific Mobile Healthcare Market, 2012 anddash; 2020 ($million)andnbsp;8.5. RoW Healthcare Market, 2012 anddash; 2020 ($million)CHAPTER 9 COMPANY PROFILESandnbsp;9.1. Philips healthcareandnbsp;andnbsp;andnbsp; 9.1.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.1.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.1.3. Strategiesandnbsp;andnbsp;andnbsp; 9.1.4. SWOT Analysisandnbsp;9.2. Omron HealthCare Inc.andnbsp;andnbsp;andnbsp; 9.2.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.2.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.2.3. Strategiesandnbsp;andnbsp;andnbsp; 9.2.4. SWOT Analysisandnbsp;9.3. Bayer Healthcareandnbsp;andnbsp;andnbsp; 9.3.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.3.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.3.3. Strategiesandnbsp;andnbsp;andnbsp; 9.3.4. SWOT Analysisandnbsp;9.4. LifeWatchandnbsp;andnbsp;andnbsp; 9.4.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.4.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.4.3. Strategiesandnbsp;andnbsp;andnbsp; 9.4.4. SWOT Analysisandnbsp;9.5. Cardionet Inc.andnbsp;andnbsp;andnbsp; 9.5.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.5.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.5.3. Strategiesandnbsp;andnbsp;andnbsp; 9.5.4. SWOT Analysisandnbsp;9.6. Masimo Corporationandnbsp;andnbsp;andnbsp; 9.6.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.6.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.6.3. Strategiesandnbsp;andnbsp;andnbsp; 9.6.4. SWOT Analysisandnbsp;9.7. Sanofiandnbsp;andnbsp;andnbsp; 9.7.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.7.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.7.3. Strategiesandnbsp;andnbsp;andnbsp; 9.7.4. SWOT Analysisandnbsp;9.8. Boston Scientificandnbsp;andnbsp;andnbsp; 9.8.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.8.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.8.3. Strategiesandnbsp;andnbsp;andnbsp; 9.8.4. SWOT Analysisandnbsp;9.9. ATandamp;T Inc.andnbsp;andnbsp;andnbsp; 9.9.1. Company Overviewandnbsp;andnbsp;andnbsp; 9.9.2. Key Financialsandnbsp;andnbsp;andnbsp; 9.9.3. Strategiesandnbsp;andnbsp;andnbsp; 9.9.4. SWOT Analysisandnbsp;9.10. Johnson andamp; Johnsonandnbsp;andnbsp;andnbsp;andnbsp; 9.10.1. Company Overviewandnbsp;andnbsp;andnbsp;andnbsp; 9.10.2. Key Financialsandnbsp;andnbsp;andnbsp;andnbsp; 9.10.3. Strategiesandnbsp;andnbsp;andnbsp;andnbsp; 9.10.4. SWOT AnalysisLIST OF TABLES:TABLE 1 GLOBAL MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)TABLE 2 SMARTPHONE PENETRATION IN THE U.S.TABLE 3 GLOBAL MHEALTH DEVICES MARKET REVENUES, BY DEVICES, 2013 anddash; 2020 ($MILLION)TABLE 4 GLOBAL MHEALTH DEVICES MARKET REVENUES, BY DEVICES, 2013 anddash; 2020 ($MILLION)TABLE 5 BLOOD GLUCOSE METERS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020TABLE 6 BP MONITORS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 7 PULSE OXIMETERY METERS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 8 NEUROLOGICAL MONITORS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 9 CARDIAC MONITORS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 10 APNEA andamp; SLEEP MONITORS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 11 WEARABLE FITNESS SENSOR DEVICES AND HEART RATE METERS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 andnbsp;($MILLION)TABLE 12 OTHER MONITORS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 13 GLOBAL MHEALTH SERVICE MARKET REVENUES, BY TYPE, 2013 anddash; 2020 ($MILLION)TABLE 14 GLOBAL MHEALTH SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 15 WELLNESS SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 16 PREVENTION SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 17 TREATMENT SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 18 DIAGNOSIS SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 19 MONITORING SERVICE MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 20 HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 21 GLOBAL MHEALTH MARKET REVENUES, BY STAKEHOLDERS, 2013 anddash; 2020 ($MILLION)TABLE 22 GLOBAL MHEALTH MARKET REVENUES, BY THERAPEUTICS, 2013 anddash; 2020 ($MILLION)TABLE 23 PREVALENCE AND PROJECTIONS (DIABETES)TABLE 24 GLOBAL NUMBER OF DISABILITY-ADJUSTED LIFE YEARS (DALY) FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 andnbsp;AND 2030TABLE 25 IMPACT ANALYSIS PERTAINING TO GEOGRAPHYTABLE 26 GLOBAL MHEALTH MARKET REVENUES, BY GEOGRAPHY, 2013 anddash; 2020 ($MILLION)TABLE 27 LIFEWATCH AG COMPANY SNAPSHOTTABLE 28 CARDIONET, INC. COMPANY SNAPSHOTTABLE 29 MASIMO CORPORATION COMPANY SNAPSHOTTABLE 30 OMRON HEALTHCARE COMPANY SNAPSHOTTABLE 31 PHILIPS HEALTHCARE COMPANY SNAPSHOTTABLE 32 BAYER HEALTHCARE COMPANY SNAPSHOTTABLE 33 SANOFI COMPANY SNAPSHOTTABLE 34 BOSTON SCIENTIFIC COMPANY SNAPSHOTTABLE 35 ATandamp;T INC. COMPANY SNAPSHOTTABLE 36 JOHNSON andamp; JOHNSON COMPANY SNAPSHOTLIST OF FIGURES:FIG. 1 GLOBAL MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 2 MHEALTH MARKET DEFINITIONFIG. 3 TOP TEN FACTORS IMPACTING MHEALTH MARKETFIG. 4 TOP WINNING STRATEGIES IN THE MHEALTH MARKETFIG. 5 MARKET PLAYER POSITIONINGFIG. 6 TOP MARKETS IN MHEALTH DEVICES MARKETFIG. 7 TOP MARKETS IN MHEALTH SERVICES MARKETFIG. 8 TOP MARKETS IN MHEALTH SERVICES MARKETFIG. 9 PORTERandrsquo;S FIVE FORCE ANALYSISFIG. 10 DEATHS DUE TO CVDSFIG. 11 GLOBAL HEALTH EXPENDITURE ON DIABETESFIG. 12 GLOBAL MHEALTH WELLNESS SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 13 GLOBAL MHEALTH PREVENTION SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 14 GLOBAL MHEALTH TREATMENT SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 15 GLOBAL MHEALTH DIAGNOSIS SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 16 GLOBAL MHEALTH MONITORING SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 17 GLOBAL MHEALTH HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS SERVICE MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 18 GLOBAL MOBILE OPERATORS MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 19 GLOBAL DEVICE VENDORS MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 20 GLOBAL HEALTHCARE PROVIDERS MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 21 GLOBAL APPLICATION/CONTENT PLAYERS MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 22 GLOBAL MHEALTH MARKET REVENUES, BY CARDIOVASCULAR DISEASE TYPE, 2013 anddash; 2020 ($MILLION)FIG. 23 GLOBAL MHEALTH MARKET REVENUES, BY DIABETES DISEASE TYPE, 2013 anddash; 2020 ($MILLION)FIG. 24 ASTHMA PREVALENCE PERCENTAGES, BY AGE, SEX, AND RACE, UNITED STATES, 2011FIG. 25 GLOBAL MHEALTH MARKET REVENUES, BY RESPIRATORY DISEASE TYPE, 2013 anddash; 2020 ($MILLION)FIG. 26 GLOBAL MHEALTH MARKET REVENUES, BY NEUROLOGICAL DISEASE TYPE, 2013 anddash; 2020 ($MILLION)FIG. 27 NORTH AMERICA MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 28 EUROPE MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 29 ASIA PACIFIC MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 30 ROW MHEALTH MARKET REVENUES, 2013 anddash; 2020 ($MILLION)FIG. 31 FINANCIAL REVENUES, BY BUSINESS UNITS (2012)FIG. 32 FINANCIAL REVENUES, BY GEOGRAPHY (2012)FIG. 33 SWOT ANALYSIS OF LIFEWATCH AGFIG. 34 FINANCIAL REVENUES, BY BUSINESS UNITS (2012)FIG. 35 FINANCIAL REVENUES, BY GEOGRAPHY (2012)FIG. 36 SWOT ANALYSIS OF CARDIONETFIG. 37 SWOT ANALYSIS OF MASIMO CORPORATIONSFIG. 38 FINANCIAL REVENUES, BY BUSINESS UNITS (2012)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.